Merck’s chronic cough drug fails to secure FDA approval for the second time
FDA denies accelerated approval for Clene’s ALS candidate
Medtech’s biggest winners in 2023
Sanofi’s oncology strategy suffers another blow as ADC scrapped over phase 3 lung cancer fail
